Senior Eyecare Business Development & In-Licensing Director

Egroup Us; United Kingdom; Remote; GBP 120,000 - 180,000; Full time

Benefits offered by this job

Performance related bonus

24 days annual leave (pro rata)

Healthcare allowance

Pension contributions

Company sick pay

Further Education policy

Professional Membership

Job summary

Scope is seeking a Business Development & In-Licensing Director to build and lead Scope’s BD and licensing capabilities for eyecare. You will identify opportunities, evaluate assets and partnerships, and drive investment decisions with scientific, clinical and financial perspectives.

Reporting to the CEO, you will shape strategy, establish governance, grow the team and lead priority transactions from initial evaluation through negotiation and handover, with international scope in UK, Ireland or

Qualifications

• PhD, MD or equivalent scientific/clinical qualification in ophthalmology or adjacent field.
• Business Degree or MBA.

Responsibilities

• Set BD and in-licensing strategy aligned with Scope's long-range plan.
• Build and lead the function, recruiting a Market Intelligence & Opportunity Specialist and growing the team.
• Chair the internal BD screening committee and guide opportunities through governance.
• Partner with Commercial, Medical, Regulatory and Finance to assess deals and value.
• Lead licensing, partnership and acquisition negotiations from term sheet to signature.
• Represent Scope at key partnering events and ensure strong external relationships.

Skills

Pharma BD

Licensing

Board‑level comms

Ophthalmology network

Education

PhD, MD or equivalent

MBA

Job description

Scope is seeking a Business Development & In-Licensing Director to build and lead Scope’s BD and licensing capabilities for eyecare. You will identify opportunities, evaluate assets and partnerships, and drive investment decisions with scientific, clinical and financial perspectives.

Reporting to the CEO, you will shape strategy, establish governance, grow the team and lead priority transactions from initial evaluation through negotiation and handover, with international scope in UK, Ireland or